Raven Biotechnologies Company
.jpg)
Raven biotechnologies is focused on the development of monoclonal antibody therapeutics for the treatment of cancer.
Total Funding:
$88 300 000
Headquarters:
South San Francisco, California, United States
Funding Status:
M&A
Last Funding Type:
Series D
Industry:
Women Cancer Treatment